Glutaminase

Glutaminase
Name	Glutaminase
Ec number	3.5.1.2

Glutaminase Glutaminase is a mitochondrial enzyme that catalyzes the hydrolysis of glutamine to glutamate and ammonia, playing a central role in cellular nitrogen metabolism, neurotransmitter cycling, and intermediary metabolism. It intersects key pathways implicated in Krebs cycle, oxidative phosphorylation, amino acid metabolism, and central nervous system physiology, and is studied across fields from biochemistry to oncology. Its activity is modulated by developmental, hormonal, and pathological cues studied in diverse systems including Escherichia coli, Homo sapiens, and model organisms such as Mus musculus and Drosophila melanogaster.

Introduction

Glutaminase functions at the crossroads of metabolic and signaling networks in tissues such as brain, kidney, and tumor microenvironments, influencing processes studied by laboratories at institutions like National Institutes of Health, Max Planck Society, and Cold Spring Harbor Laboratory. It was characterized in classical enzymology studies alongside enzymes such as glutamate dehydrogenase and enzymes from the Tricarboxylic Acid Cycle literature, and its physiological importance has been highlighted in research connected to Alzheimer's disease, Parkinson's disease, and cancer metabolism explored at centers like Dana-Farber Cancer Institute and MD Anderson Cancer Center.

Structure and Isoforms

Mammalian glutaminase exists as multiple isoforms encoded by genes with tissue-specific expression patterns, with structural insights provided by crystallography groups at facilities like European Synchrotron Radiation Facility and Advanced Photon Source. Isoforms differ in oligomeric state and regulatory domains, analogous to structural variations seen in enzymes studied by teams at Max Planck Institute for Biophysical Chemistry and Salk Institute. High-resolution structures show active sites and allosteric pockets comparable to other amidases investigated in structural biology programs at Wellcome Trust Sanger Institute and European Molecular Biology Laboratory.

Biological Function and Regulation

Glutaminase supplies glutamate for neurotransmission in circuits analyzed by researchers at Salk Institute and Cold Spring Harbor Laboratory and fuels anaplerosis for the Krebs cycle in proliferating cells studied at Broad Institute and Francis Crick Institute. Its regulation involves post-translational modifications, interaction with regulatory proteins studied in labs at Harvard Medical School and Stanford University School of Medicine, and allosteric modulation by metabolites similar to mechanisms characterized in classic studies at University of Cambridge and University of Oxford. Hormonal and developmental regulation has been documented in systems researched at National Institute of Mental Health and European Research Council-funded consortia.

Clinical Significance and Disease Associations

Altered glutaminase activity is implicated in neurodegenerative disorders and excitotoxicity described in literature from Columbia University Irving Medical Center and University College London, and in oncogenesis and tumor growth investigated at Memorial Sloan Kettering Cancer Center and Johns Hopkins University. Mutations, dysregulation, or differential isoform expression relate to pathologies studied by clinical programs at Mayo Clinic and Cleveland Clinic. It is considered a metabolic vulnerability in malignancies explored in clinical trials coordinated by networks including National Cancer Institute and translational research hubs like Fred Hutchinson Cancer Center.

Pharmacology and Inhibitors

Small-molecule inhibitors and biologics targeting glutaminase have been developed and tested in preclinical and clinical studies at pharmaceutical companies and academic centers such as Genentech, AstraZeneca, Pfizer, and translational groups at Massachusetts General Hospital. Inhibitors modulate tumor metabolism and neuronal glutamate levels, paralleling drug development strategies used for targets studied at Novartis Institutes for BioMedical Research and Merck Research Laboratories. Combination strategies and biomarker-driven trials involve collaborations with consortia like European Organisation for Research and Treatment of Cancer and Alliance for Clinical Trials in Oncology.

Methods of Study and Assays

Glutaminase is assayed using enzymology approaches refined in laboratories at Rockefeller University and University of California, Berkeley, including spectrophotometric, chromatographic, and mass spectrometry methods developed at institutions like Lawrence Berkeley National Laboratory. Structural studies employ cryo-electron microscopy and X-ray crystallography performed at facilities such as Diamond Light Source and National Synchrotron Light Source II. Genetic and cellular perturbation studies use tools originated from programs at Broad Institute (CRISPR), Addgene (plasmids), and imaging methods advanced at Howard Hughes Medical Institute-supported laboratories.

Category:Enzymes